Our approach to allergen immunotherapy
Stallergenes Greer is committed to promoting progress in AIT. Find out more about our approach to AIT.
Our objective is the development of pharmaceutical specialties aimed at treating the major respiratory allergies. Find out more about clinical development.
As biologic drugs, the manufacture of allergen products is inherently challenging and complex. Find out more about manufacturing.